Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022
by from Morbidity and Mortality Weekly Report (MMWR) on (#61DTN)
This report describes safety of the COVID-19 mRNA vaccine among immunocompromised persons 12 years or older.